Davita - Garrisonville is a medicare approved dialysis facility center in Stafford, Virginia and it has 13 dialysis stations. It is located in Stafford county at 70 Doc Stone Rd #101, Stafford, VA, 22556. You can reach out to the office of Davita - Garrisonville at (540) 658-1135. This dialysis clinic is managed and/or owned by Davita. Davita - Garrisonville has the following ownership type - Profit. It was first certified by medicare in June, 2006. The medicare id for this facility is 492637 and it accepts patients under medicare ESRD program.
| Name | Davita - Garrisonville |
|---|---|
| Location | 70 Doc Stone Rd #101, Stafford, Virginia |
| No. of Dialysis Stations | 13 |
| Medicare ID | 492637 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 70 Doc Stone Rd #101, Stafford, Virginia, 22556 | |
| (540) 658-1135 | |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
| NPI Number | 1225076714 |
| Doing Business As | Total Renal Care Inc |
| Address | 70 Doc Stone Rd Stafford, Virginia, 22556 |
| Phone Number | (240) 893-2521 |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
| Dialysis patients with Hemoglobin data | 13 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 31 |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 34 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 263 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Garrisonville with elevated calcium levels.
| Patients with hypercalcemia | 35 |
| Hypercalcemia patient months | 275 |
| Patients with Serumphosphor | 35 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 31 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 14 |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 32 |
| Patient months included in arterial venous fistula and catheter summaries | 186 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 80 |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 35 |
| Hospitalization Rate in facility | 207.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 430.3 |
| Hospitalization Rate: Lower Confidence Limit | 105.6 |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Garrisonville were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.8 |
| Readmission Rate: Lower Confidence Limit | 20.2 |
News Archive
Capping many months of campaigning across the U.S., nurses from National Nurses United (NNU) – the largest union of registered nurses in the country – brought their urgent message for a financial transaction tax (FTT) to Washington, D.C., today, rallying in front of the White House and Department of Treasury. It was the second time since June that NNU brought its demands to the nation's capital.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company, announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking.
A new study by Lyle Hood, assistant professor of mechanical engineering at The University of Texas at San Antonio, describes a new device that could revolutionize the delivery of medicine to treat cancer as well as a host of other diseases and ailments.
In addition to responding to electrical and chemical stimuli, many of the body's neural cells can also respond to mechanical effects, such as pressure or vibration.
John DeLuca, PhD, vice president for research at Kessler Foundation, is the featured speaker at the grand opening of the new Science Complex at William Paterson University's College of Science and Health. Dr. DeLuca, a well known expert in cognitive function, will discuss "Neuroimaging, Brain and Behavior: New Opportunities for the Future," on March 1, 2012 12:30 to 1:05 pm in the Science East Lecture Hall.
› Verified 7 days ago